Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.thromres.2020.12.024 http://scihub22266oqcxt.onion/10.1016/j.thromres.2020.12.024 33503547!7787910!33503547     free     free     free Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 263.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Thromb+Res 2021 ; 199 (ä): 132-142 Nephropedia Template TP {{tp|p=33503547|t=2021. Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: A retrospective study |pdf=|usr=}}{{33503547}} gab.com Text Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: A retrospective study JO: Thromb Res http://www.kidney.de/pget.php?&tw=1&pmid=33503547 #FOAvip BACKGROUND: Incidence of thrombotic events associated to Coronavirus disease-2019 (COVID-19) is difficult to assess and reported rates differ significantly. Optimal thromboprophylaxis is unclear. OBJECTIVES: We aimed to analyze the characteristics of patients with a confirmed thrombotic complication including inflammatory and hemostatic parameters, compare patients affected by arterial vs venous events and examine differences between survivors and non-survivors. We reviewed compliance with thromboprophylaxis and explored how the implementation of a severity-adjusted protocol could have influenced outcome. METHODS: Single-cohort retrospective study of COVID-19 patients admitted, from March 3 to May 3 2020, to the Infanta Leonor University Hospital in Madrid, epicenter of the Spanish outbreak. RESULTS: Among 1127 patients, 80 thrombotic events were diagnosed in 69 patients (6.1% of the entire cohort). Forty-three patients (62%) suffered venous thromboembolism, 18 (26%) arterial episodes and 6 (9%) concurrent venous and arterial thrombosis. Most patients (90%) with a confirmed thrombotic complication where under low-molecular-weight heparin treatment. Overt disseminated intravascular coagulation (DIC) was rare. Initial ISTH DIC score and pre-event CRP were significantly higher among non-survivors. In multivariate analysis, arterial localization was an independent predictor of mortality (OR = 18, 95% CI: 2.4-142, p < .05). CONCLUSIONS: Despite quasi-universal thromboprophylaxis, COVID-19 lead to a myriad of arterial and venous thrombotic events. Considering the subgroup of patients with thrombotic episodes, arterial events appeared earlier in the course of disease and conferred very poor prognosis, and an ISTH DIC score >/= 3 at presentation was identified as a potential predictor of mortality. Severity-adjusted thromboprophylaxis seemed to decrease the number of events and could have influenced mortality. Randomized controlled trials are eagerly awaited. Twit Text FOAVip Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: A retrospective study ????Thromb Res http://www.kidney.de/pget.php?&tw=1&pmid=33503547 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33503547 #FOAvip English Wikipedia <ref>{{Cite pmid|33503547}}</ref> Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: A retrospective study #MMPMID33503547 Munoz-Rivas N; Abad-Motos A; Mestre-Gomez B; Sierra-Hidalgo F; Cortina-Camarero C; Lorente-Ramos RM; Torres-Rubio P; Arranz-Garcia P; Franco-Moreno AI; Gomez-Mariscal E; Mauleon-Fernandez C; Alonso-Garcia S; Rogado J; Saez-Vaquero T; Such-Diaz A; Ryan P; Moya-Mateo E; Martin-Navarro JA; Hernandez-Rivas JA; Torres-Macho J; Churruca J Thromb Res 2021[Mar]; 199 (ä): 132-142 PMID33503547show ga BACKGROUND: Incidence of thrombotic events associated to Coronavirus disease-2019 (COVID-19) is difficult to assess and reported rates differ significantly. Optimal thromboprophylaxis is unclear. OBJECTIVES: We aimed to analyze the characteristics of patients with a confirmed thrombotic complication including inflammatory and hemostatic parameters, compare patients affected by arterial vs venous events and examine differences between survivors and non-survivors. We reviewed compliance with thromboprophylaxis and explored how the implementation of a severity-adjusted protocol could have influenced outcome. METHODS: Single-cohort retrospective study of COVID-19 patients admitted, from March 3 to May 3 2020, to the Infanta Leonor University Hospital in Madrid, epicenter of the Spanish outbreak. RESULTS: Among 1127 patients, 80 thrombotic events were diagnosed in 69 patients (6.1% of the entire cohort). Forty-three patients (62%) suffered venous thromboembolism, 18 (26%) arterial episodes and 6 (9%) concurrent venous and arterial thrombosis. Most patients (90%) with a confirmed thrombotic complication where under low-molecular-weight heparin treatment. Overt disseminated intravascular coagulation (DIC) was rare. Initial ISTH DIC score and pre-event CRP were significantly higher among non-survivors. In multivariate analysis, arterial localization was an independent predictor of mortality (OR = 18, 95% CI: 2.4-142, p < .05). CONCLUSIONS: Despite quasi-universal thromboprophylaxis, COVID-19 lead to a myriad of arterial and venous thrombotic events. Considering the subgroup of patients with thrombotic episodes, arterial events appeared earlier in the course of disease and conferred very poor prognosis, and an ISTH DIC score >/= 3 at presentation was identified as a potential predictor of mortality. Severity-adjusted thromboprophylaxis seemed to decrease the number of events and could have influenced mortality. Randomized controlled trials are eagerly awaited. |Aged[MESH] |Aged, 80 and over[MESH] |Anticoagulants/*therapeutic use[MESH] |COVID-19/*complications[MESH] |Disseminated Intravascular Coagulation/diagnosis/drug therapy/etiology[MESH] |Female[MESH] |Heparin, Low-Molecular-Weight/*therapeutic use[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Retrospective Studies[MESH] |SARS-CoV-2/isolation & purification[MESH] |Thrombophilia/diagnosis/drug therapy/etiology[MESH] |Thrombosis/diagnosis/*drug therapy/*etiology[MESH]Systemic thrombosis in a large cohort of COVID-19 patients despite th(epmc).pdf DeepDyve Pubget Overpricing